Effects of Intravenous Immunoglobulin and Acyclovir in Preventing Neonatal Varicella
Neonatal varicella mostly results from maternal varicella. The disease can cause presentation ranging from mild symptoms to varicella pneumonia, hepatitis, meningoencephalitis, or fatality. If the mother develops symptoms implying varicella 4–5 days antepartum to 2 days postpartum, the mortality rat...
Main Author: | Waritsara Piyanonpong |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Case Reports in Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2020/2709389 |
Similar Items
-
Is acyclovir effective for the treatment of varicella in children and adolescents?
by: Felipe González
Published: (2018-10-01) -
Adjuvant treatment of severe varicella pneumonia with intravenous varicella zoster virus-specific immunoglobulins
by: Davide Mangioni, et al.
Published: (2019-08-01) -
Varicella Exposure in Neonatal Intensive Care Unit in a Low Resource Country: Successful Prophylaxis with Intravenous Immunoglobulins
by: Manar Al-lawama, et al.
Published: (2019-03-01) -
Use of intravenous immunoglobulin in a disseminated varicella infection in an immunocompromised child
by: Jae Hong Kim, et al.
Published: (2014-08-01) -
The Effects and Pharmacokinetics of Acyclovir in Neonates
by: Gian Maria Pacifici
Published: (2016-12-01)